ethylnitrosourea has been researched along with Osteosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevrollier, A; Demidem, A; Douay, O; Loiseau, D; Morvan, D; Reynier, P; Stepien, G | 1 |
| Bedigian, HG; Fox, RR; Meier, H; Pottathil, R | 1 |
| Berger, MR; Klenner, T; Rao, NU; Schmähl, D; Sosnovsky, G; Wingen, F | 1 |
3 other study(ies) available for ethylnitrosourea and Osteosarcoma
| Article | Year |
|---|---|
Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
Topics: Adenosine Triphosphate; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Cell Respiration; Cell Survival; Energy Metabolism; Ethylnitrosourea; Glucose; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Membrane Potential, Mitochondrial; Mitochondria; Osteosarcoma; Oxidative Phosphorylation; Pyruvic Acid; Tumor Cells, Cultured | 2009 |
Transplacental teratogenic and carcinogenic effects in rabbits chronically treated with N-ethyl-N-nitrosourea.
Topics: Animals; Carcinogens; Ethylnitrosourea; Female; Jaw Neoplasms; Kidney Neoplasms; Limb Deformities, Congenital; Maternal-Fetal Exchange; Neurofibroma; Nitrosourea Compounds; Osteosarcoma; Parietal Bone; Pregnancy; Rabbits; Rats; Spinal Cord Neoplasms; Teratogens; Wilms Tumor | 1980 |
Evaluation of spin labeled TEPA and CCNU analogs against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat.
Topics: Animals; Antineoplastic Agents; Azirines; Bone Neoplasms; Cyclic N-Oxides; Dose-Response Relationship, Drug; Ethylnitrosourea; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasm Transplantation; Nitrosourea Compounds; Osteosarcoma; Rats; Rats, Inbred Strains; Triethylenephosphoramide | 1989 |